103 related articles for article (PubMed ID: 15254692)
21. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
22. Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis.
Zhang X; Hunt JL; Landsittel DP; Muller S; Adler-Storthz K; Ferris RL; Shin DM; Chen ZG
Clin Cancer Res; 2004 Dec; 10(24):8451-9. PubMed ID: 15625067
[TBL] [Abstract][Full Text] [Related]
23. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
Sinha UK; Mazhar K; Chinn SB; Dhillon VK; Liu L; Masood R; Rice DH; Gill PS
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1053-9. PubMed ID: 17043250
[TBL] [Abstract][Full Text] [Related]
24. Defining the glycophenotype of squamous epithelia using plant and mammalian lectins. Differentiation-dependent expression of alpha2,6- and alpha2,3-linked N-acetylneuraminic acid in squamous epithelia and carcinomas, and its differential effect on binding of the endogenous lectins galectins-1 and -3.
Holíková Z; Hrdlicková-Cela E; Plzák J; Smetana K; Betka J; Dvoránková B; Esner M; Wasano K; André S; Kaltner H; Motlík J; Hercogová J; Kodet R; Gabius HJ
APMIS; 2002 Dec; 110(12):845-56. PubMed ID: 12645662
[TBL] [Abstract][Full Text] [Related]
25. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
Patel V; Hood BL; Molinolo AA; Lee NH; Conrads TP; Braisted JC; Krizman DB; Veenstra TD; Gutkind JS
Clin Cancer Res; 2008 Feb; 14(4):1002-14. PubMed ID: 18281532
[TBL] [Abstract][Full Text] [Related]
27. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB
Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099
[TBL] [Abstract][Full Text] [Related]
28. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
Scher RL
Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
[TBL] [Abstract][Full Text] [Related]
29. A study of TRAIL receptors in squamous cell carcinoma of the head and neck.
Teng MS; Brandwein-Gensler MS; Teixeira MS; Martignetti JA; Duffey DC
Arch Otolaryngol Head Neck Surg; 2005 May; 131(5):407-12. PubMed ID: 15897419
[TBL] [Abstract][Full Text] [Related]
30. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
[TBL] [Abstract][Full Text] [Related]
31. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
32. CD44s and CD44v6 expression in head and neck epithelia.
Mack B; Gires O
PLoS One; 2008; 3(10):e3360. PubMed ID: 18852874
[TBL] [Abstract][Full Text] [Related]
33. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
34. Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients.
Jin C; Jin Y; Wennerberg J; Rosenquist B; Mertens F
Mutat Res; 2008 Mar; 652(1):30-7. PubMed ID: 18243046
[TBL] [Abstract][Full Text] [Related]
35. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
[TBL] [Abstract][Full Text] [Related]
36. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of RAD17 in head and neck cancer.
Zhao M; Begum S; Ha PK; Westra W; Califano J
Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
[TBL] [Abstract][Full Text] [Related]
38. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer.
Kudo Y; Ogawa I; Kitajima S; Kitagawa M; Kawai H; Gaffney PM; Miyauchi M; Takata T
Cancer Res; 2006 Jul; 66(14):6928-35. PubMed ID: 16849536
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of MUC1 and carbohydrate antigens in primary and secondary head and neck squamous cell carcinoma.
Croce MV; Rabassa ME; Pereyra A; Segal-Eiras A
Head Neck; 2008 May; 30(5):647-57. PubMed ID: 18302268
[TBL] [Abstract][Full Text] [Related]
40. Keratin 8 expression in head and neck epithelia.
Matthias C; Mack B; Berghaus A; Gires O
BMC Cancer; 2008 Sep; 8():267. PubMed ID: 18803884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
